Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786460 · ClinicalTrials.gov registry record
Brain Injury Biomarkers in the General Population
A clinical trial of Brain Injuries, Traumatic, sponsored by Banyan Biomarkers.
- Completed
- Registry status
- 800
- Enrollment target
- 5
- Study locations
NCT01786460: Completed study of Brain Injuries, Traumatic, sponsored by Banyan Biomarkers.
NCT01786460 is a study of Brain Injuries, Traumatic that has completed, run by Banyan Biomarkers. The registered enrollment target is 800 participants, above the 218-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (267% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01786460, a study of Brain Injuries, Traumatic, has completed, sponsored by Banyan Biomarkers.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to use an investigational assay to assess levels of putative biomarkers of traumatic brain injury (TBI) in a general population. The data will be used in a correlative analysis with data collected under a separate study of severe TBI.
Conditions Studied
Interventions
- OTHER Blood draw at Days 0, 7, 14, and 21
Study Locations (5)
Georgia
- Dekalb Medical Center - Decatur
- Gwinnett Medical Center - Lawrenceville
California
- Office of Nagi S. Ibrahim - Vista
Florida
- Shands at University Florida Gainesville - Gainesville
Massachusetts
- New England Center for Clinical Research - Fall River
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-09 |
What the finished NCT01786460 record still lists
NCT01786460 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 218-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (267% higher).
The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Blood draw at Days 0, 7, 14, and 21 is the first listed.
NCT01786460 lists 5 locations in 4 states (Georgia, California, Florida).
Frequently Asked Questions
What is clinical trial NCT01786460 about?
NCT01786460 is a clinical study titled "Brain Injury Biomarkers in the General Population". The purpose of this study is to use an investigational assay to assess levels of putative biomarkers of traumatic brain injury (TBI) in a general population. The data will be used in a correlative analysis with data collected under a separate study of severe TBI.
What is the current status of trial NCT01786460?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2011-01. Estimated completion is 2011-09.
What conditions does trial NCT01786460 study?
This clinical trial studies the following conditions: Brain Injuries, Traumatic.
What interventions are being tested in trial NCT01786460?
The interventions under investigation include: Blood draw at Days 0, 7, 14, and 21 (OTHER).
Who is sponsoring clinical trial NCT01786460?
This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01786460 being conducted?
This trial has 5 study locations across California, Florida, Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01786460's enrollment target sits among peer trials
800 2nd of 21 the highest of 21 other Brain Injuries, Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries, Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Morning Bright Light to Improve Sleep Quality in Veterans
RECRUITING · NA
-
mTBI Identification and Monitoring Through Retinal Scanning
RECRUITING
-
Automated Robotic TCD in Traumatic Brain Injury
RECRUITING
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Brain Oxygen Optimization in Severe TBI, Phase 3
RECRUITING · NA
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia